The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RCKT FINANCIAL STATEMENTS

Rocket Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

RCKTRocket Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-2.1 M $ · -Infinity%Operating Income-191.6 M $ · -Infinity%Pre-tax Income-8.6 M $ · -Infinity%Net Income to Owners-17.3 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-2.1 M $—
Operating Income-191.6 M $—
EBITDA8 M $—
Net Income to Owners-17.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets423.1 M
  • Equity368.8 M $87%
  • Current Liabilities31.3 M $7%
  • Long-term Liabilities22.9 M $5%

Key Figures

YoY change
Total Assets423.1 M $+0.5%
Total Liabilities54.3 M $-18.7%
Total Equity368.8 M $+4.1%
Cash & ST Investments283.7 M $+4.5%
Total Debt24.8 M $-1.6%
Net Debt-199.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M0100 M200 M-170.3 M $Operating361.8 M $Investing92 K $Financing191.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-170.3 M $—
Capital Expenditures235 K $-89.8%
Free Cash Flow-170.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RCKT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.